Description
Once daily clinical potency MygraFew is standardised to 2% parthenolide, 3X more potent than other feverfew extracts. Studies at the London Migraine Clinic have increased interest in the parthenolide in feverfew for its role in helping to maintain blood vessel tone. MygraFew helps maintain normal blood vessel tone by reducing platelet aggregation, serotonin release from platelets and blocking the formation of pro-inflammatory mediators.
Usage: Migraine prevention.
Usage: Migraine prevention.